CALCA and Parkinson disease: It also plays a role in dopamine-related nervous system disorders, such as Parkinson’s disease [69,70], and treatment with CGRP monoclonal antibodies alleviates functional abdominal pain, associated with various pathologies, including during the COVID-19 pandemic [71,72].